Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment [0.03%]
探索和应对泌尿生殖系统肿瘤治疗的发展与变迁
Marcus Hentrich,Stefanie Zschäbitz
Marcus Hentrich
Ismini Kyriacou,Dionysios Vaidakis,Constantina Constantinou
Ismini Kyriacou
Background: Ovarian cancer is a prevalent and highly lethal gynaecological cancer. Among its various subtypes, epithelial ovarian cancer predominates, comprising of ten distinct subtypes and contributing significantly to ...
Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiation [0.03%]
结构化的磁共振成像评估可改善新辅助放化疗后直肠癌病理完全缓解的诊断率
Moying Li,Tobias Dieckmann,Florian Herrle et al.
Moying Li et al.
Introduction: Precise prediction of pathological complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT) in rectal cancer may identify candidates for non-operative management. The optimal selection of diagn...
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer Centers [0.03%]
我国综合癌症中心allo-HSCT受者缓和医疗实施情况的横断面调查研究
Anne Pralong,Marco Herling,Udo Holtick et al.
Anne Pralong et al.
Introduction: Specialist palliative care (SPC) is rarely integrated into the management of patients with an allogeneic hematopoietic stem-cell transplantation, despite considerable symptom burden and mortality. We aimed t...
Marta Raposo
Marta Raposo
Published Erratum
Oncology research and treatment. 2025 Aug 19:1. DOI:10.1159/000547344 2025
Patient-Reported Outcome in metastatic breast cancer and platinum-resistant recurrent ovarian cancer patients treated with metronomic cyclophosphamide ± methotrexate: PROmetronomic [0.03%]
单药或联合叶酸代谢途径抑制剂小剂量口服环磷酰胺治疗转移性乳腺癌和铂耐药复发卵巢癌患者的疗效及安全性：PROmetronomic研究
Slavomir Krajnak,Marco Johannes Battista,Ina Shehaj et al.
Slavomir Krajnak et al.
Introduction: Maintenance of subjective well-being and health-related quality of life (HRQoL) play a crucial role in the treatment of metastatic cancer. The metronomic chemotherapy (MCT) may be a favorable treatment optio...
Gunhild von Amsberg,Tobias Busenbender,Anja Coym et al.
Gunhild von Amsberg et al.
Background: Advanced stages of prostate cancer (PCa), in particular metastatic castration-resistant prostate cancer (mCRPC), are associated with significant morbidity and mortality. The androgen receptor (AR) signaling pa...
Gerhard Emrich
Gerhard Emrich
The potential impact of neoadjuvant therapy and the role of circulating tumor DNA (ctDNA) analysis were key discussion points at the 2025 ASCO Annual Meeting. Updated results from the phase 3 EV-302 trial were also presented with impressive...
Lynch Syndrome in context of the updated German S3 guideline Colorectal Cancer - Implementation of universal MMR/MSI-testing [0.03%]
Lynch综合征更新的德国S3指南结直肠癌-MMR/MSI普适性检测实施背景下
Deepak B Vangala,Thomas Seufferlein,Robert Hüneburg
Deepak B Vangala
Background: With 1:280 carriers, Lynch Syndrome (LS) is the most prevalent tumor predisposition syndrome and the most important cause for hereditary colorectal cancer (CRC). Tumors from affected individuals usually presen...
Pancreatic Cancer Highlights from the European Society for Medical Oncology (ESMO) Annual Meeting 2024 in Barcelona [0.03%]
2024年欧洲医学肿瘤学会（ESMO）年会巴塞罗那胰腺癌亮点报告
Sabrina Sulzer,Marianne Sinn,Annabel Alig et al.
Sabrina Sulzer et al.
No abstract section included in the article template. © 2025 S. Karger AG, Basel.